Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
|
LIGAND PHARMACEUTICALS INC (LGND)
|
|
| Credit Analysis |
|
|
|
|
Annual | Quarterly |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-05-18 | Dec-31-17 | Dec-05-17 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Short-term debt | | | | | 26.4 | | 224.5 | |
| Long-term debt | | 320.7 | 442.3 | 639.0 | 609.9 | | | |
| Total debt | | 320.7 | 442.3 | 639.0 | 636.3 | | 224.5 | |
| Net debt | | | 31.1 | | | | 22.9 | |
| |
| Debt to EBITDA | | 2.5 | 8.6 | 0.8 | 3.6 | | 2.8 | |
| Net debt to EBITDA | | | 0.6 | | | | 0.3 | |
| |
| EBITDA interest coverage | | 6.6 | 1.9 | 23.1 | 3.7 | | 5.9 | |
| EBIT interest coverage | | 4.0 | 0.9 | 22.6 | 3.4 | | 5.1 | 6.0 |
|